CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
To date, two phenotypes produced by DNMT1 mutations have been reported, including hereditary sensory and autonomic neuropathy (HSAN) type IE with mutations in exon 20, and autosomal dominant cerebellar ataxia, deafness, and narcolepsy caused by mutations in exon 21.
|
23521649 |
2013 |
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
HSAN IE and ADCA-DN are two extreme phenotypic manifestations of a DNMT1 methylopathy.
|
24727570 |
2014 |
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT
|
0.770 |
GeneticVariation
|
disease |
UNIPROT |
We performed exome sequencing in five individuals from three ADCA-DN kindreds and identified DNMT1 as the only gene with mutations found in all five affected individuals.
|
22328086 |
2012 |
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
Missense mutations in the DNMT1 gene have been previously associated with two neurological syndromes: hereditary sensory and autonomic neuropathy type 1 with dementia and deafness (HSAN1E) and autosomal dominant cerebellar ataxia, deafness, and narcolepsy (ADCA-DN).
|
27277422 |
2016 |
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
The two asymptomatic carriers of the heterozygous DNMT1 mutation for ADCA-DN, a late-onset neurodegenerative disease, presented with SOREMPs associated with an increase of mI in the brain, a marker of glial cell activity and density characteristic of early stages of neurodegenerative diseases.
|
24709307 |
2014 |
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT
|
0.770 |
GeneticVariation
|
disease |
BEFREE |
Autosomal dominant cerebellar ataxia, deafness and narcolepsy (ADCA-DN) is caused by DNMT1 mutations.
|
23904686 |
2013 |
Hereditary Sensory and Autonomic Neuropathy Type Ie
|
0.720 |
GeneticVariation
|
disease |
BEFREE |
We previously discovered DNMT1 mutations cause hereditary sensory and autonomic neuropathy type 1 with dementia and hearing loss (HSAN1E; OMIM 614116).
|
25033457 |
2014 |
Hereditary Sensory and Autonomic Neuropathy Type Ie
|
0.720 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Hereditary Sensory and Autonomic Neuropathy Type Ie
|
0.720 |
GeneticVariation
|
disease |
BEFREE |
Identification of a novel DNMT1 mutation in a Chinese patient with hereditary sensory and autonomic neuropathy type IE.
|
30342480 |
2018 |
Hereditary Sensory and Autonomic Neuropathy Type Ie
|
0.720 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss.
|
21532572 |
2011 |
Dementia
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
We report on the extensive phenotypic characterization of five Italian patients from four unrelated families carrying dominant heterozygous DNMT1 mutations linked to two distinct autosomal dominant diseases: hereditary sensory and autonomic neuropathy with dementia and hearing loss type IE (HSAN IE) and autosomal dominant cerebellar ataxia, deafness and narcolepsy (ADCA-DN).
|
24727570 |
2014 |
Dementia
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
Here we show that mutations in DNMT1 cause both central and peripheral neurodegeneration in one form of hereditary sensory and autonomic neuropathy with dementia and hearing loss.
|
21532572 |
2011 |
Dementia
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
As mutations in DNMT1 cause a rare dominant form of narcolepsy in association with deafness, cerebellar ataxia and dementia, we questioned whether the association with P2RY11 in sporadic narcolepsy could be secondary to linkage disequilibrium with DNMT1.
|
25669430 |
2015 |
Dementia
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
Mutations in DNMT1 were specific to 2 HSAN1E kindreds with dementia and hearing loss (no narcolepsy).
|
23365052 |
2013 |
Dementia
|
0.450 |
GeneticVariation
|
disease |
BEFREE |
And mutations in DNMT1 can induce one form of neurodegenerative diseases with dementia and sensorineural hearing loss.
|
23771421 |
2013 |
Malignant neoplasm of breast
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We hypothesized that heritable methylation potential might be a risk factor for breast cancer and evaluated possible association with breast cancer for single nucleotide polymorphisms (SNPs) either involving CpG sequences in extended 5'-regulatory regions of candidate genes (ESR1, ESR2, PGR, and SHBG) or CpG and missense coding SNPs in genes involved in methylation (MBD1, MECP2, DNMT1, MGMT, MTHFR, MTR, MTRR, MTHFD1, MTHFD2, BHMT, DCTD, and SLC19A1).
|
21105050 |
2011 |
Malignant neoplasm of breast
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Our data suggest that there is no apparent association of common DNMT-1 and DNMT-3B polymorphisms with the risk of breast cancer among Chinese women.
|
19798569 |
2010 |
Malignant neoplasm of breast
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Hypermethylated E2F transcription factor 1 (E2F1) motif is a key regulatory element for the DNMT1 gene in BRCA1-mutated breast cancer.
|
24502362 |
2014 |
Malignant neoplasm of breast
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Two SNPs, rs16999593 in DNMT1 and rs2424908 in DNMT3B, were significantly associated with breast cancer risk.
|
23079992 |
2012 |
Malignant neoplasm of breast
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
A hypermethylation defect associated with DNMT hyperactivity and DNMT3b overexpression characterizes a subset of breast cancers and breast cancer cell lines.
|
22664488 |
2012 |
Malignant tumor of colon
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
However, statistically significant interactions modifying CC risk were observed for DNMT1 I311V with dietary folate, methionine, vitamin B2 , and vitamin B12 intake and for MTRR I22M with dietary folate, a predefined one-carbon dietary pattern, and vitamin B6 intake.
|
22961839 |
2013 |
Malignant neoplasm of stomach
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
No mutation in the 5'-flanking region of the DNMT1 gene was detected in any of the colorectal and stomach cancers or HCCs.
|
12637155 |
2003 |
Malignant neoplasm of stomach
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We could not show any association between DNMT1 polymorphisms and gastric cancer.
|
20192608 |
2009 |
Malignant neoplasm of stomach
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We aimed to assess the effect of DNMTs polymorphisms on the susceptibility to GC.
|
27789275 |
2016 |
Malignant neoplasm of stomach
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
This study suggests that five genetic variations of interest in DNMT1 and DNMT3A are not associated with the presence of gastric cancer, but that rs13420827 may contribute to the gastric cancer risk for those younger individuals, the risk of which may be influenced by the characteristics of tumor.
|
29956566 |
2018 |